QuidelOrtho Corporation (QDEL)
USD 42.46
(-1.32%)
USD 42.46
(-1.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.49 Billion USD | -33.71% |
| 2022 | 1.93 Billion USD | 52.33% |
| 2021 | 1.27 Billion USD | -5.78% |
| 2020 | 1.34 Billion USD | 320.46% |
| 2019 | 320.8 Million USD | 1.61% |
| 2018 | 315.71 Million USD | 102.2% |
| 2017 | 156.14 Million USD | 32.11% |
| 2016 | 118.18 Million USD | -5.02% |
| 2015 | 124.44 Million USD | 14.76% |
| 2014 | 108.43 Million USD | 0.0% |
| 2013 | 108.43 Million USD | 14.8% |
| 2012 | 94.45 Million USD | -1.34% |
| 2011 | 95.73 Million USD | 57.64% |
| 2010 | 60.73 Million USD | -44.32% |
| 2009 | 109.06 Million USD | 39.96% |
| 2008 | 77.92 Million USD | 12.14% |
| 2007 | 69.49 Million USD | 13.55% |
| 2006 | 61.19 Million USD | 10.87% |
| 2005 | 55.19 Million USD | 27.02% |
| 2004 | 43.45 Million USD | -16.9% |
| 2003 | 52.29 Million USD | 37.59% |
| 2002 | 38 Million USD | -2.01% |
| 2001 | 38.78 Million USD | 21.78% |
| 2000 | 31.84 Million USD | 0.0% |
| 1998 | 24.4 Million USD | -0.81% |
| 1997 | 24.6 Million USD | -0.4% |
| 1996 | 24.7 Million USD | 19.9% |
| 1995 | 20.6 Million USD | 21.89% |
| 1994 | 16.9 Million USD | 15.75% |
| 1993 | 14.6 Million USD | 0.69% |
| 1992 | 14.5 Million USD | 6.62% |
| 1991 | 13.6 Million USD | -3.55% |
| 1990 | 14.1 Million USD | 166.04% |
| 1989 | 5.3 Million USD | 55.88% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 277.8 Million USD | -13.19% |
| 2024 Q2 | 223.5 Million USD | -19.55% |
| 2023 Q2 | 296.4 Million USD | -33.93% |
| 2023 Q1 | 448.6 Million USD | -0.09% |
| 2023 FY | 1.28 Billion USD | -33.71% |
| 2023 Q3 | 368.1 Million USD | 24.19% |
| 2023 Q4 | 320 Million USD | -13.07% |
| 2022 FY | 1.93 Billion USD | 52.33% |
| 2022 Q1 | 739.95 Million USD | 51.21% |
| 2022 Q2 | 337.5 Million USD | -54.39% |
| 2022 Q3 | 407.5 Million USD | 20.74% |
| 2022 Q4 | 449 Million USD | 10.18% |
| 2021 Q4 | 489.34 Million USD | 31.05% |
| 2021 FY | 1.27 Billion USD | -5.78% |
| 2021 Q2 | 106.18 Million USD | -64.83% |
| 2021 Q3 | 373.4 Million USD | 251.65% |
| 2021 Q1 | 301.95 Million USD | -56.95% |
| 2020 Q1 | 114.99 Million USD | 21.25% |
| 2020 Q4 | 701.49 Million USD | 82.86% |
| 2020 FY | 1.34 Billion USD | 320.46% |
| 2020 Q3 | 383.61 Million USD | 157.89% |
| 2020 Q2 | 148.75 Million USD | 29.36% |
| 2019 FY | 320.8 Million USD | 1.61% |
| 2019 Q2 | 59.17 Million USD | -34.92% |
| 2019 Q1 | 90.92 Million USD | 10.71% |
| 2019 Q4 | 94.84 Million USD | 25.02% |
| 2019 Q3 | 75.85 Million USD | 28.19% |
| 2018 FY | 315.71 Million USD | 102.2% |
| 2018 Q1 | 106.27 Million USD | 79.73% |
| 2018 Q3 | 69.64 Million USD | 20.76% |
| 2018 Q2 | 57.66 Million USD | -45.73% |
| 2018 Q4 | 82.13 Million USD | 17.93% |
| 2017 Q1 | 50.12 Million USD | 48.78% |
| 2017 FY | 156.14 Million USD | 32.11% |
| 2017 Q4 | 59.12 Million USD | 87.69% |
| 2017 Q3 | 31.5 Million USD | 53.58% |
| 2017 Q2 | 20.51 Million USD | -59.08% |
| 2016 Q3 | 31.61 Million USD | 44.91% |
| 2016 FY | 118.18 Million USD | -5.02% |
| 2016 Q4 | 33.68 Million USD | 6.57% |
| 2016 Q1 | 31.07 Million USD | -9.38% |
| 2016 Q2 | 21.81 Million USD | -29.79% |
| 2015 Q2 | 19.38 Million USD | -51.78% |
| 2015 FY | 124.44 Million USD | 14.76% |
| 2015 Q3 | 29.85 Million USD | 54.03% |
| 2015 Q1 | 40.19 Million USD | -5.06% |
| 2015 Q4 | 34.29 Million USD | 14.87% |
| 2014 Q4 | 42.33 Million USD | 75.74% |
| 2014 Q2 | 15.58 Million USD | -41.02% |
| 2014 Q1 | 26.42 Million USD | -16.08% |
| 2014 FY | 108.43 Million USD | 0.0% |
| 2014 Q3 | 24.08 Million USD | 54.56% |
| 2013 Q1 | 42.44 Million USD | 16.85% |
| 2013 Q3 | 18.24 Million USD | 13.76% |
| 2013 FY | 108.43 Million USD | 14.8% |
| 2013 Q4 | 31.49 Million USD | 72.63% |
| 2013 Q2 | 16.03 Million USD | -62.22% |
| 2012 Q3 | 18.12 Million USD | 7.57% |
| 2012 Q2 | 16.85 Million USD | -27.22% |
| 2012 Q1 | 23.15 Million USD | 0.2% |
| 2012 FY | 94.45 Million USD | -1.34% |
| 2012 Q4 | 36.32 Million USD | 100.42% |
| 2011 Q4 | 23.1 Million USD | 27.57% |
| 2011 Q1 | 39.55 Million USD | 120.99% |
| 2011 FY | 95.73 Million USD | 57.64% |
| 2011 Q2 | 14.96 Million USD | -62.15% |
| 2011 Q3 | 18.11 Million USD | 21.0% |
| 2010 Q1 | 15.02 Million USD | -68.4% |
| 2010 Q4 | 17.89 Million USD | 16.09% |
| 2010 Q3 | 15.41 Million USD | 24.44% |
| 2010 Q2 | 12.39 Million USD | -17.54% |
| 2010 FY | 60.73 Million USD | -44.32% |
| 2009 Q4 | 47.54 Million USD | 23.56% |
| 2009 Q2 | 14.56 Million USD | 72.08% |
| 2009 Q1 | 8.46 Million USD | -57.06% |
| 2009 Q3 | 38.48 Million USD | 164.15% |
| 2009 FY | 109.06 Million USD | 39.96% |
| 2008 Q1 | 26.73 Million USD | 17.09% |
| 2008 FY | 77.92 Million USD | 12.14% |
| 2008 Q4 | 19.71 Million USD | -0.41% |
| 2008 Q3 | 19.79 Million USD | 69.59% |
| 2008 Q2 | 11.67 Million USD | -56.34% |
| 2007 FY | 69.49 Million USD | 13.55% |
| 2007 Q2 | 9.26 Million USD | -55.85% |
| 2007 Q4 | 22.83 Million USD | 39.14% |
| 2007 Q3 | 16.41 Million USD | 77.15% |
| 2007 Q1 | 20.98 Million USD | -10.65% |
| 2006 FY | 61.19 Million USD | 10.87% |
| 2006 Q4 | 23.48 Million USD | 75.56% |
| 2006 Q3 | 13.37 Million USD | 71.44% |
| 2006 Q2 | 7.8 Million USD | -52.82% |
| 2006 Q1 | 16.53 Million USD | -24.65% |
| 2005 Q1 | 14.29 Million USD | -27.29% |
| 2005 Q4 | 21.94 Million USD | 104.12% |
| 2005 Q3 | 10.75 Million USD | 31.12% |
| 2005 Q2 | 8.2 Million USD | -42.65% |
| 2005 FY | 55.19 Million USD | 27.02% |
| 2004 Q1 | 10.33 Million USD | -48.25% |
| 2004 FY | 43.45 Million USD | -16.9% |
| 2004 Q2 | 6.87 Million USD | -33.49% |
| 2004 Q3 | 6.58 Million USD | -4.23% |
| 2004 Q4 | 19.66 Million USD | 198.72% |
| 2003 Q3 | 9.46 Million USD | -1.35% |
| 2003 Q4 | 19.97 Million USD | 111.1% |
| 2003 Q2 | 9.59 Million USD | -27.73% |
| 2003 Q1 | 13.27 Million USD | 15.09% |
| 2003 FY | 52.29 Million USD | 37.59% |
| 2002 FY | 38 Million USD | -2.01% |
| 2002 Q4 | 11.53 Million USD | 74.56% |
| 2002 Q1 | 11.23 Million USD | -2.61% |
| 2002 Q2 | 8.64 Million USD | -23.07% |
| 2002 Q3 | 6.6 Million USD | -23.55% |
| 2001 Q3 | 8.49 Million USD | 15.75% |
| 2001 Q4 | 11.53 Million USD | 35.73% |
| 2001 FY | 38.78 Million USD | 21.78% |
| 2001 Q1 | 10.55 Million USD | 26.7% |
| 2001 Q2 | 7.34 Million USD | -30.43% |
| 2000 Q3 | 3.51 Million USD | -59.33% |
| 2000 Q4 | 8.32 Million USD | 137.17% |
| 2000 Q1 | 13.08 Million USD | 0.0% |
| 2000 FY | 31.84 Million USD | 0.0% |
| 2000 Q2 | 8.63 Million USD | -34.0% |
| 1999 Q2 | 6.1 Million USD | 60.53% |
| 1999 Q1 | 3.8 Million USD | -51.28% |
| 1999 Q3 | 7.1 Million USD | 16.39% |
| 1998 FY | 24.4 Million USD | -0.81% |
| 1998 Q1 | 6.7 Million USD | -4.29% |
| 1998 Q2 | 5.5 Million USD | -17.91% |
| 1998 Q4 | 7.8 Million USD | 25.81% |
| 1998 Q3 | 6.2 Million USD | 12.73% |
| 1997 Q2 | 4.7 Million USD | -33.8% |
| 1997 Q4 | 7 Million USD | 1.45% |
| 1997 FY | 24.6 Million USD | -0.4% |
| 1997 Q1 | 7.1 Million USD | 2.9% |
| 1997 Q3 | 6.9 Million USD | 46.81% |
| 1996 FY | 24.7 Million USD | 19.9% |
| 1996 Q4 | 6.9 Million USD | 13.11% |
| 1996 Q3 | 6.1 Million USD | 15.09% |
| 1996 Q2 | 5.3 Million USD | 8.16% |
| 1996 Q1 | 4.9 Million USD | -12.5% |
| 1995 Q1 | 4.7 Million USD | -12.96% |
| 1995 Q2 | 5.1 Million USD | 8.51% |
| 1995 Q3 | 5 Million USD | -1.96% |
| 1995 Q4 | 5.6 Million USD | 12.0% |
| 1995 FY | 20.6 Million USD | 21.89% |
| 1994 FY | 16.9 Million USD | 15.75% |
| 1994 Q4 | 5.4 Million USD | 50.0% |
| 1994 Q3 | 3.6 Million USD | 28.57% |
| 1994 Q2 | 2.8 Million USD | -56.25% |
| 1994 Q1 | 6.4 Million USD | 106.45% |
| 1993 Q1 | 4.3 Million USD | 13.16% |
| 1993 Q4 | 3.1 Million USD | -8.82% |
| 1993 FY | 14.6 Million USD | 0.69% |
| 1993 Q3 | 3.4 Million USD | 3.03% |
| 1993 Q2 | 3.3 Million USD | -23.26% |
| 1992 Q4 | 3.8 Million USD | 0.0% |
| 1992 Q1 | 3.9 Million USD | 18.18% |
| 1992 Q2 | 2.9 Million USD | -25.64% |
| 1992 Q3 | 3.8 Million USD | 31.03% |
| 1992 FY | 14.5 Million USD | 6.62% |
| 1991 Q4 | 3.3 Million USD | 37.5% |
| 1991 Q1 | 7 Million USD | 0.0% |
| 1991 FY | 13.6 Million USD | -3.55% |
| 1991 Q2 | 2.6 Million USD | -62.86% |
| 1991 Q3 | 2.4 Million USD | -7.69% |
| 1990 Q2 | 6.9 Million USD | 176.0% |
| 1990 Q1 | 2.5 Million USD | 4.17% |
| 1990 Q4 | 7 Million USD | 1.45% |
| 1990 FY | 14.1 Million USD | 166.04% |
| 1990 Q3 | 6.9 Million USD | 0.0% |
| 1989 FY | 5.3 Million USD | 55.88% |
| 1989 Q1 | 2 Million USD | -13.04% |
| 1989 Q2 | 1.8 Million USD | -10.0% |
| 1989 Q4 | 2.4 Million USD | 4.35% |
| 1989 Q3 | 2.3 Million USD | 27.78% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -2554.116% |
| AngioDynamics, Inc. | 154.69 Million USD | -866.011% |
| AtriCure, Inc. | 300.37 Million USD | -397.52% |
| Avinger, Inc. | 2 Million USD | -74508.088% |
| Azenta, Inc. | 263.14 Million USD | -467.911% |
| BioLife Solutions, Inc. | 46.75 Million USD | -3096.441% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 36.622% |
| Daxor Corporation | 1.1 Million USD | -135331.016% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -16359.963% |
| Femasys Inc. | 691.9 Thousand USD | -215884.657% |
| GlucoTrack, Inc. | -13 Thousand USD | 11495484.615% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -2355.23% |
| Hologic, Inc. | 2.22 Billion USD | 32.92% |
| ICU Medical, Inc. | 739.87 Million USD | -101.981% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 68.403% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -8844.067% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -1076.239% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1252435.979% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1252435.979% |
| Masimo Corporation | 1 Billion USD | -48.919% |
| Microbot Medical Inc. | -106 Thousand USD | 1409911.321% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -4415.485% |
| Merit Medical Systems, Inc. | 583.87 Million USD | -155.947% |
| Nephros, Inc. | 8.4 Million USD | -17679.893% |
| NovoCure Limited | 381.05 Million USD | -292.171% |
| NEXGEL, Inc. | 619 Thousand USD | -241321.648% |
| NEXGEL, Inc. | 619 Thousand USD | -241321.648% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 267913.62% |
| OraSure Technologies, Inc. | 179.42 Million USD | -732.901% |
| Pro-Dex, Inc. | 14.55 Million USD | -10170.085% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 123911.102% |
| Predictive Oncology Inc. | 1.14 Million USD | -130381.438% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -25675.396% |
| Repligen Corporation | 315.22 Million USD | -374.07% |
| Sanara MedTech Inc. | 57.13 Million USD | -2515.461% |
| STAAR Surgical Company | 252.65 Million USD | -491.488% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 167774.991% |
| Utah Medical Products, Inc. | 30.03 Million USD | -4875.032% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 28.36% |
| Jin Medical International Ltd. | 6.78 Million USD | -21925.594% |